Adaptimmune Therapeutics
ADAP
#8253
Rank
NZ$0.27 B
Marketcap
$1.09
Share price
-4.23%
Change (1 day)
49.93%
Change (1 year)

Adaptimmune Therapeutics (ADAP) Fails to deliver data

Key failure to deliver metrics for Adaptimmune Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Adaptimmune Therapeutics (ADAP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Adaptimmune Therapeutics (ADAP) - since 2015

Volume in USD (price x number of shares), data since 2015

Adaptimmune Therapeutics (ADAP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.57 M-86.75%
2023NZ$4.31 M424.88%
2022NZ$0.82 M-74.5%
2021NZ$3.22 M-92.83%
2020NZ$44.92 M883.34%
2019NZ$4.56 M-18.66%
2018NZ$5.61 M202.64%
2017NZ$1.85 M182.01%
2016NZ$0.65 M-91.71%
2015NZ$7.93 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$15.83 MNZ$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0 MNZ$0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.6 MNZ$3.61 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$5.76 MNZ$11.62 M๐Ÿ‡บ๐Ÿ‡ธ USA